Shattuck Labs (STTK) Interest Coverage Ratio (2019 - 2025)
Shattuck Labs' (STTK) quarterly Interest Coverage Ratio came in at 0.13 in Q4 2025, up 38.98% year-on-year from 0.09 in Q4 2024, and up 99.53% on a QoQ basis from 26.79 in Q3 2025.
Shattuck Labs (STTK) Interest Coverage Ratio (2019 - 2025) Analysis & Trends
Shattuck Labs (STTK) has 7 years of Interest Coverage Ratio data on file, last reported at 0.13 in Q4 2025.
- On a quarterly basis, Interest Coverage Ratio rose 38.98% year-over-year to 0.13 in Q4 2025; TTM through Mar 2026 was 263.32, a N/A change from a year earlier, with the FY2025 full-year figure at 0.48, up 42.7% from the prior year.
- Interest Coverage Ratio for Q4 2025 stood at 0.13, up from 26.79 in the prior quarter.
- Over the last five years, Interest Coverage Ratio for STTK reached as high as 131.38 in Q4 2022 and fell as low as 285.98 in Q3 2023.
- Historically, Interest Coverage Ratio has averaged 29.8 across 5 years, with a median of 3.48 in 2022.
- Across the five-year window, Interest Coverage Ratio soared 42998.49% in 2022 and plunged 7203.38% in 2023, its largest moves.
- Year by year, Interest Coverage Ratio stood at 0.3 in 2021, then surged by 42998.49% to 131.38 in 2022, then plunged by 100.19% to 0.25 in 2023, then rose by 17.21% to 0.21 in 2024, then jumped by 38.98% to 0.13 in 2025.
- Per Business Quant data, the three most recent Interest Coverage Ratio figures were 0.13 in Q4 2025, 26.79 in Q3 2025, and 130.32 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Shattuck Labs | 795.74 Mn | 795.74 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -0.13 |
| Sep 30, 2025 | -26.79 |
| Jun 30, 2025 | -130.32 |
| Dec 31, 2024 | -0.21 |
| Sep 30, 2024 | -22.40 |
| Jun 30, 2024 | -17.66 |
| Mar 31, 2024 | -1.62 |
| Dec 31, 2023 | -0.25 |
| Sep 30, 2023 | -285.98 |
| Jun 30, 2023 | -75.82 |
| Mar 31, 2023 | -108.31 |
| Dec 31, 2022 | 131.38 |
| Sep 30, 2022 | -3.92 |
| Jun 30, 2022 | -18.60 |
| Mar 31, 2022 | -3.48 |
| Dec 31, 2021 | 0.30 |
| Sep 30, 2021 | -0.91 |
| Jun 30, 2021 | -0.94 |
| Mar 31, 2021 | -0.47 |
| Dec 31, 2020 | -0.69 |